WS
ARMP icon

Wedbush Securities’s Armata Pharmaceuticals ARMP Stock Holding History

Wedbush Securities’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,103
Closed -$32K – 875
2020
Q3 		$32K Buy
+10,103
New +$35.5K ﹤0.01% 906

Other funds holding ARMP

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Wedbush Securities's ARMP Position: Q4 2020 in Review

Wedbush Securities sold out of Armata Pharmaceuticals (ARMP) in Q4 2020, closing a stake of 10,103 shares — an estimated $32K sold.

Wedbush Securities first reported a position in ARMP in Q3 2020 and held it in 1 quarter. The position peaked at $32K in Q3 2020. 19 funds tracked by Wall St. Rank hold ARMP as of Q4 2020.

  • Wedbush Securities reported no remaining Armata Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Wedbush Securities sold 10,103 Armata Pharmaceuticals shares in Q4 2020, an estimated $32K.
  • Wedbush Securities first reported a position in Armata Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Wedbush Securities's Armata Pharmaceuticals position peaked at $32K in Q3 2020.
  • 19 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.